Call 911 Severe dizziness that does not resolve, difficulty breathing, or signs of an allergic reaction such as a rash or swelling of the face or throat are emergencies
Orforglipron Name: Orforglipron Manufacturer: Eli Lilly Current stage: Expected to submit for regulatory approval by the end of 2025 Takeaway: Less effective than injectables for mean weight loss, but a daily pill could suit some patients better
Indian patients with the skinny-fat phenotype often see dramatic improvements in waist circumference and metabolic markers even with modest overall weight loss
18 In a trial evaluating the impact of liraglutide on weight loss in T2D and obesity, an average weight loss of 6.4 kg was seen with liraglutide 3 mg daily and 5-kg loss with liraglutide 1.8 mg daily, versus 2.2 kg with placebo, at 56-week follow-up
Thus, its better to inform the medical health provider if patients have a history of eye problems or Lebers disease (whether its patient or a family member)
In addition, we tested for co-localization with expression quantitative trait loci in the locus, and identified none that colocalized with the GWAS signal (Supplementary Information)